RCMI INFRASTRUCTURE FOR CLINICAL AND TRANSLATIONAL RESEARCH (RCTR) (U54)
RCMI 临床和转化研究基础设施 (RCTR) (U54)
基本信息
- 批准号:8173608
- 负责人:
- 金额:$ 55.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAreaClinicalCommunitiesComputer Retrieval of Information on Scientific Projects DatabaseEnvironmentFacultyFosteringFundingGoalsGrantGrowthHealthHealth StatusInstitutionInvestmentsKnowledgeMentorsMinorityModelingPublic HealthRecruitment ActivityResearchResearch InfrastructureResearch PersonnelResearch ProposalsResourcesScienceScientistSolutionsSourceStrategic PlanningStudentsTalentsTrainingTranslatingTranslational ResearchUnited States National Institutes of Healthbasebiomedical scientistclinical infrastructuredesignexperiencehealth disparityinnovationinterdisciplinary approachmedical schoolsmultidisciplinarynext generationprogramsracial and ethnic disparitiessuccess
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
DESCRIPTION (provided by applicant): The long-term goal of the Morehouse School of Medicine (MSM) RCMI Center of Excellence in Clinical and Translational Research (R-CENTER) is to train the next generation of minority clinical and translational scientists to pursue multidisciplinary approaches to discovery science that translate into the amelioration of health disparities. MSM has experienced tremendous growth and success of its research enterprise over the past decade based on a strategic plan that focuses our talent and resources in discrete areas that will serve the needs of minority communities. This R-CENTER proposal builds upon the foundational infrastructure developed with the careful stewardship and investments of RCMI resources over the past decade. Our approach is to further enhance our research capacity in clinical and translational science by building effective partnerships and seeking synergies that leverage the collective strengths of our talented faculty, trainees, students and collaborators. The R-CENTER's institution-wide organizational framework and key functions are designed to promote transformative changes in our research environment that will enhance our research capacity in clinical/translational science by pursuing the following specific aims
Aim I: Transform Our Institution. Establish an organizational framework for conducting clinical/ translational research that promotes multidisciplinary approaches to addressing health disparities.
Aim II: Transform Our Research Environment. Establish a robust research infrastructure and vibrant training environment that fosters innovative, multidisciplinary clinical/translational research.
Aim III: Transform the Community of Biomedical Scientists - Training the Next Generation. Establish an institution-wide mechanism for recruiting, training and mentoring a critical mass of talented faculty engaged in multidisciplinary clinical/translational research.
Aim IV: Transform Our Community. Establish a community-centered model of clinical/translational research that advances discovery science and translates new knowledge into improvements in the health status of minority communities.
Overall, the implementation of these specific aims will enable MSM to fulfill its long-term goal of translating discovery science into community-based solutions that ameliorate health disparities.
PUBLIC HEALTH RELEVENCE (provided by the applicant): Minority-serving academic health centers such as MSM are strategically poised to make important scientific contributions that address the devastating problem of racial/ethnic disparities of health in the US. The proposed R-CENTER program will enable MSM investigators to establish the research infrastructure and capacity necessary to pursue discovery science that will translate into improvements in the health status of the minority communities we serve.
该副本是利用众多研究子项目之一
由NIH/NCRR资助的中心赠款提供的资源。子弹和
调查员(PI)可能已经从其他NIH来源获得了主要资金,
因此可以在其他清晰的条目中代表。列出的机构是
对于中心,这不一定是调查员的机构。
描述(由申请人提供):Morehouse医学院(MSM)RCMI临床和转化研究卓越中心(R-Center)的长期目标是培训下一代少数族裔临床和转化科学家,以追求发现科学的多学科方法,从而转化为健康矛盾的偏爱。在过去的十年中,MSM基于一项战略计划,在过去的十年中经历了巨大的增长和成功,该计划将我们的人才和资源集中在离散领域,这些地区将满足少数民族社区的需求。这项R-Center提案建立在过去十年中仔细管理和RCMI资源投资的基础基础设施基础上。我们的方法是通过建立有效的合作伙伴关系并寻求协同作用来进一步增强我们在临床和转化科学方面的研究能力,从而利用我们才华横溢的教师,受训者,学生和合作者的集体优势。 R-Center在机构范围内的组织框架和关键功能旨在促进我们的研究环境中的变革性变化,从而通过追求以下特定目标来增强我们的临床/转化科学研究能力
目标I:改变我们的机构。建立一个组织框架,用于进行临床/翻译研究,以促进解决健康差异的多学科方法。
AIM II:改变我们的研究环境。建立强大的研究基础设施和充满活力的培训环境,以促进创新的多学科临床/转化研究。
AIM III:改变生物医学科学家的社区 - 培训下一代。建立一种范围内的机构机制,用于招募,培训和指导从事多学科临床/转化研究的重要教师。
AIM IV:改变我们的社区。建立一个以社区为中心的临床/翻译研究模型,该模型可以推进发现科学,并将新知识转化为少数民族社区健康状况的改善。
总体而言,这些特定目标的实施将使MSM能够实现其将发现科学转化为改善健康差异的基于社区的解决方案的长期目标。
公共卫生相关性(由申请人提供):诸如MSM之类的少数群体服务的学术健康中心有望做出重要的科学贡献,以解决美国健康危害的毁灭性问题。拟议的R-Center计划将使MSM调查人员能够建立追求发现科学所必需的研究基础设施和能力,以改善我们所服务的少数群体的健康状况。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EVE J. HIGGINBOTHAM其他文献
EVE J. HIGGINBOTHAM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EVE J. HIGGINBOTHAM', 18)}}的其他基金
RCMI INFRASTRUCTURE FOR CLINICAL AND TRANSLATIONAL RESEARCH (RCTR) (U54)
RCMI 临床和转化研究基础设施 (RCTR) (U54)
- 批准号:
7961255 - 财政年份:2009
- 资助金额:
$ 55.9万 - 项目类别:
RCMI Infrastructure for Clinical and Translational Research (RCTR) (U54)
RCMI 临床和转化研究基础设施 (RCTR) (U54)
- 批准号:
7939128 - 财政年份:2009
- 资助金额:
$ 55.9万 - 项目类别:
RCMI Infrastructure for Clinical and Translational Research (RCTR) (U54)
RCMI 临床和转化研究基础设施 (RCTR) (U54)
- 批准号:
7938517 - 财政年份:2009
- 资助金额:
$ 55.9万 - 项目类别:
RCMI Infrastructure for Clinical and Translational Research (RCTR) (U54)
RCMI 临床和转化研究基础设施 (RCTR) (U54)
- 批准号:
7938518 - 财政年份:2009
- 资助金额:
$ 55.9万 - 项目类别:
RCMI INFRASTRUCTURE FOR CLINICAL AND TRANSLATIONAL RESEARCH (RCTR) (U54)
RCMI 临床和转化研究基础设施 (RCTR) (U54)
- 批准号:
7961254 - 财政年份:2009
- 资助金额:
$ 55.9万 - 项目类别:
Research Centers in Minority Institutions Clinical Rese*
少数民族机构临床研究研究中心*
- 批准号:
7471430 - 财政年份:1995
- 资助金额:
$ 55.9万 - 项目类别:
相似国自然基金
国际多区域等效性临床试验中区域一致性的统计学方法研究
- 批准号:81803335
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
基于稳健估计模型的多区域临床试验(MRCT)的方法学研究
- 批准号:81872710
- 批准年份:2018
- 资助金额:58.0 万元
- 项目类别:面上项目
基于贝叶斯层次模型的国际多区域临床研究中目标区域药物有效性和安全性的评估方法研究
- 批准号:81773553
- 批准年份:2017
- 资助金额:60.0 万元
- 项目类别:面上项目
多区域临床试验设计及统计方法研究
- 批准号:81302512
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
恶性血液病中20q-的共同缺失区域、该区域内相关基因、基因表达谱及其临床意义研究
- 批准号:81100332
- 批准年份:2011
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Implementation of Innovative Treatment for Moral Injury Syndrome: A Hybrid Type 2 Study
道德伤害综合症创新治疗的实施:2 型混合研究
- 批准号:
10752930 - 财政年份:2024
- 资助金额:
$ 55.9万 - 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 55.9万 - 项目类别:
Fluency from Flesh to Filament: Collation, Representation, and Analysis of Multi-Scale Neuroimaging data to Characterize and Diagnose Alzheimer's Disease
从肉体到细丝的流畅性:多尺度神经影像数据的整理、表示和分析,以表征和诊断阿尔茨海默病
- 批准号:
10462257 - 财政年份:2023
- 资助金额:
$ 55.9万 - 项目类别: